DVIU and Urethral Dilation
Direct vision internal urethrotomy (DVIU) and urethral dilation are the two core endoscopic treatments for male urethral stricture disease. They are best understood together: both open the narrowed lumen without excising the scar, both are low morbidity, both are useful for urgent access, and both have modest long-term durability outside carefully selected short bulbar strictures.[1][2][3]
The AUA guideline treats dilation and DVIU as interchangeable options for initial treatment of appropriate short strictures, with best outcomes in short bulbar disease and sharply diminishing success as length, recurrence, penile location, or dense spongiofibrosis increases.[1] For definitive reconstruction strategy, see Urethral Reconstruction Principles. For paclitaxel-enhanced endoscopic treatment, see Drug-Coated Balloon Therapy.
Guideline Position
| Scenario | AUA-Relevant Guidance | Practical Meaning |
|---|---|---|
| Initial short stricture | Dilation or DVIU may be offered interchangeably | Choose based on anatomy, surgeon preference, equipment, and patient goals[1] |
| Urgent retention / need for catheterization | Dilation, DVIU, or suprapubic cystostomy may be used | Treat as temporizing access, then stage the stricture properly[1] |
| Catheterization after dilation/DVIU | Catheter removal after 24-72 hours is reasonable | No evidence that >72 hours improves safety or outcome[1] |
| Recurrent anterior stricture after failed dilation/DVIU | Offer urethroplasty instead of repeated endoscopic management | Repeat endoscopy has failure rates >80% in many settings[1] |
| Recurrent bulbar stricture <3 cm | Dilation/DVIU plus drug-coated balloon may be used | Evidence-supported bridge before urethroplasty in selected recurrent bulbar disease[1][4] |
| Long bulbar stricture >=2 cm | Offer urethroplasty as initial treatment | Endoscopic success is poor as length increases[1] |
Urethroplasty may also be offered as initial treatment for a short bulbar stricture after shared decision-making. The tradeoff is greater durability at the cost of anesthesia, morbidity, and recovery.[1][5]
Definitions and Principles
| Procedure | Mechanism | Core Limitation |
|---|---|---|
| DVIU | Cold knife or laser makes a controlled full-thickness incision through the stricture scar under direct vision | The wound can heal by recurrent scar contraction |
| Urethral dilation | Sequential dilators, sounds, followers, or balloon dilation stretch and split the narrowed segment | Scar is disrupted but not excised or reconstructed |
Both procedures rely on the same biologic bargain: a short scar is opened, splinted briefly, and allowed to re-epithelialize before it recontracts. That bargain works best when the stricture is short, bulbar, nonobliterative, and first-time.[1][2][3]
When Endoscopic Treatment Makes Sense
| Good Candidate | Poor Candidate |
|---|---|
| First presentation of a short bulbar stricture | Penile stricture |
| Length <1-2 cm | Bulbar stricture >=2 cm, especially >4 cm |
| Thin scar / limited spongiofibrosis | Dense spongiofibrosis or obliteration |
| Patient needs urgent drainage or temporary access | Recurrent anterior stricture after failed DVIU/dilation |
| Patient prioritizes lowest morbidity after counseling | Lichen sclerosus, hypospadias-associated, radiation-associated, or complex recurrent disease |
| Poor candidate for urethroplasty | Patient wants the most durable definitive repair |
Repeated endoscopic management should not become the default. It can delay definitive repair, increase cumulative instrumentation trauma, and train both patient and surgeon into accepting recurrence as normal.
Urethral Dilation Techniques
Filiforms and Followers
A small filiform is passed through a tight stricture and sequential followers are attached to dilate the lumen, often up to approximately 24 Fr. This can traverse very tight strictures but is a blind technique and can create false passages, instrument breakage, or traumatic bleeding if forced.[3]
Metal Sounds
Van Buren or similar sounds are passed sequentially. They provide tactile feedback and are reusable, but they are also blind instruments. The surgeon must respect urethral curvature, stop when resistance is abnormal, and avoid turning dilation into a perforation exercise.
Balloon Dilation
Balloon dilation applies radial force across the stricture rather than serial axial shearing. It may be performed under endoscopic or fluoroscopic guidance. Direct-vision balloon dilation combines visual confirmation with controlled expansion.[6]
Beeder et al. reported a 50% overall recurrence rate after balloon dilation for short bulbar and membranous strictures, establishing a useful baseline in the modern drug-coated balloon era.[7]
Guidewire Principle
For urgent catheterization or tight strictures, dilation over a guidewire is safer than blind force. If the wire cannot be passed confidently into the bladder, stop and use cystoscopy, fluoroscopy, suprapubic access, or referral.
DVIU Technique
Standard Cold-Knife DVIU
- Perform cystourethroscopy and confirm the stricture location, lumen, and estimated length.
- Pass a safety guidewire into the bladder whenever possible.
- Advance a cold-knife optical urethrotome to the distal face of the stricture.
- Incise the scar longitudinally, traditionally at 12 o'clock, until healthy vascular tissue is seen.
- Extend the incision across the full stricture into normal proximal urethra.
- Place a Foley catheter, usually 16-18 Fr, for 24-72 hours.
The goal is a full-thickness scar release, not a superficial mucosal scratch. A shallow cut behaves like inadequate dilation and fails predictably.
Laser DVIU
Ho:YAG or other lasers can be used instead of a cold knife, particularly when flexible access is useful. Laser offers hemostasis and controlled incision, but it does not solve the core recurrence biology.
Incision Direction
Classic bulbar DVIU is dorsal at 12 o'clock to avoid the ventrolateral urethral arteries. Some surgeons add 3, 9, or 6 o'clock incisions depending on scar configuration. In posterior stenosis or bladder-neck/VUAS work, incisions at 5 and 7 o'clock have been described to avoid the dorsal vascular complex, often with mitomycin C in selected salvage protocols.[8]
DVIU vs Dilation Outcomes
The best evidence synthesis shows no clear durable superiority of DVIU over dilation for uncomplicated strictures. The Cochrane review found no statistically significant difference between urethrotomy and dilation, with wide confidence intervals and generally low-quality evidence.[3]
| Finding | Evidence Signal |
|---|---|
| DVIU and dilation are similar for initial short strictures | AUA guideline treats them as interchangeable[1] |
| Best outcomes occur in short bulbar strictures | Highest success in very short lesions, especially around 1 cm[1][2] |
| Median time to recurrence is often early | Kluth et al. reported median recurrence at 6 months after DVIU[9] |
| Prior DVIU predicts failure | Prior DVIU was the only independent recurrence predictor in the Kluth series[9] |
| Repeat endoscopy performs poorly | AUA recommends urethroplasty over repeated endoscopic management for recurrent anterior strictures[1] |
| Urethroplasty is more durable | OPEN trial: fewer reinterventions after urethroplasty than urethrotomy[10][11] |
Practical Success Pattern
| Stricture Type | Endoscopic Outlook |
|---|---|
| First-time bulbar, <1 cm | Best endoscopic candidate |
| First-time bulbar, 1-2 cm | Reasonable initial DVIU/dilation after counseling |
| Bulbar >=2 cm | Urethroplasty usually preferred |
| Bulbar >4 cm | Endoscopic success may be around 20% or worse; reconstruction favored[1] |
| Penile urethral stricture | Poor DVIU/dilation candidate; urethroplasty favored |
| Recurrent anterior after failed DVIU/dilation | Urethroplasty preferred; repeat endoscopy failure often >80%[1] |
OPEN Trial
The OPEN trial randomized men with recurrent bulbar urethral stricture to open urethroplasty or endoscopic urethrotomy.[10][11]
| Endpoint | Urethroplasty | Urethrotomy | Interpretation |
|---|---|---|---|
| Voiding symptoms | Improved | Improved | Similar symptom improvement at 24 months |
| Reintervention | Less frequent | More frequent | Urethroplasty reduced repeat intervention (HR 0.52) |
| Cost over 24 months | Higher | Lower | Urethrotomy appeared more cost-effective over short horizon |
| Long-term strategy | Definitive | Temporizing / recurrence-prone | Longer follow-up favors durability logic of reconstruction |
The trial is useful because it keeps the counseling honest: endoscopy can improve symptoms, but urethroplasty is more durable.
Complications
| Complication | DVIU | Dilation |
|---|---|---|
| Bleeding / hematuria | Commonly mild; can be significant | Usually mild unless traumatic |
| False passage | Possible, especially without guidewire | Classic risk with blind dilation |
| Extravasation | Possible after deep incision | Possible after traumatic dilation |
| UTI / cystitis | Low but real risk | Low but real risk |
| Epididymitis | Reported | Reported |
| Urinary retention | Possible after catheter removal | Possible after catheter removal |
| Pain / dysuria | Common short-term | Common short-term |
| Failure to traverse | Dense strictures may require suprapubic access or reconstruction | Tightness can prevent safe dilation |
The most important "complication" is not immediate morbidity; it is recurrence followed by serial repeat procedures in a stricture that should have been reconstructed.
Catheter and Follow-Up
The AUA guideline notes catheter durations from 1-8 days in the literature but no evidence that catheterization beyond 72 hours improves outcome after uncomplicated dilation or DVIU.[1]
Typical practice:
- Foley catheter for 24-72 hours after straightforward DVIU/dilation,
- earlier removal when bleeding is minimal and access was atraumatic,
- longer drainage only for complex incisions, extravasation concern, infection, or surgeon-specific posterior stenosis protocols,
- follow-up with symptoms, uroflow/PVR, and cystoscopy or urethrography when recurrence is suspected.
Intermittent Self-Dilation
Intermittent self-dilation (ISD) can reduce or delay recurrence after DVIU/dilation but turns the stricture into a maintenance condition. It is most appropriate for patients who are not urethroplasty candidates, decline reconstruction, or need temporizing management.
| Evidence | Takeaway |
|---|---|
| AUA guideline | Self-catheterization schedules vary; use beyond 4 months reduced recurrence compared with shorter courses[1] |
| Cochrane ISD review | ISD may reduce recurrence, but evidence quality is limited[12] |
| Scheipner et al. | Patient-reported outcomes after ISD were acceptable, recurrence was 9%, and complications were low per 6-month interval[13] |
ISD should be discussed as maintenance, not cure.
Adjunctive Pharmacology
The AUA guideline allows endoscopic injection of pharmacologic agents at the time of DVIU to reduce recurrence risk, while emphasizing limited evidence.[1] The class-level pharmacology is covered in Antimitotics & Antifibrotics.
| Adjunct | Evidence Signal |
|---|---|
| Mitomycin C | Strongest adjunct evidence in meta-analysis; used for recurrent bulbar/bulbomembranous strictures and BNC/VUAS salvage[14][15][16] |
| Triamcinolone | Reduces recurrence in some studies, but protocols and adverse events vary[14] |
| Drug-coated balloon | ROBUST III showed 1-year freedom from reintervention 83.2% vs 21.7% for DCB vs standard DVIU/dilation in recurrent anterior strictures; guideline-supported use is recurrent bulbar <3 cm[1][4] |
| PRP, HA/CMC, other agents | Emerging or lower-certainty adjuncts; not routine standard |
Mitomycin C should not be treated casually. Concentration, volume, injection depth, and tissue quality matter, especially near the sphincter or after radiation.
Post-Urethroplasty Recurrence
Short annular recurrence after urethroplasty is a different clinical problem from untreated stricture disease. Endoscopic treatment may be reasonable, but results vary by repair type and recurrence pattern.
| Study | Key Finding |
|---|---|
| Sukumar et al. (TURNS) | Endoscopic success after bulbar urethroplasty recurrence was 42% overall; DVIU outperformed dilation (49% vs 10%)[17] |
| Bandini et al. | After ventral onlay BMG failure, rescue DVIU success declined with repeated attempts; open retreatment stayed more durable[18] |
Use endoscopy here as a measured salvage tool, not as an endless loop.
Decision Framework
| Clinical Scenario | Preferred Strategy |
|---|---|
| First-time short bulbar stricture | DVIU or dilation reasonable; urethroplasty also acceptable if patient wants durability |
| First-time long bulbar stricture >=2 cm | Urethroplasty |
| Penile stricture | Urethroplasty, often graft or staged repair depending tissue |
| Recurrent anterior stricture after failed DVIU/dilation | Urethroplasty |
| Recurrent bulbar stricture <3 cm, patient wants endoscopic bridge | DVIU/dilation plus drug-coated balloon |
| Urgent urinary retention | Guidewire dilation, DVIU, or suprapubic cystostomy, followed by definitive staging |
| Poor surgical candidate | DVIU/dilation with adjuncts and/or ISD as maintenance |
| Short recurrence after substitution urethroplasty | Consider DVIU before open redo in selected annular recurrences |
Operative Pearls
- Stage the stricture before treating it when possible: RUG/VCUG, cystoscopy, and sometimes ultrasound define whether endoscopy is reasonable.
- Use a guidewire for tight strictures and urgent catheterization.
- Do not force blind dilation. False passage creation converts a simple problem into a worse one.
- A short first-time bulbar stricture is the endoscopic sweet spot.
- A penile, long, obliterative, lichen sclerosus, or multiply recurrent stricture is not the endoscopic sweet spot.
- Remove uncomplicated catheters early, usually within 24-72 hours.
- After one failed endoscopic treatment, pause and re-stage instead of reflexively repeating the same operation.
- Explain that ISD is maintenance and that urethroplasty is the durable option for recurrence.
Summary
DVIU and urethral dilation are low-morbidity, interchangeable first-line endoscopic options for carefully selected short bulbar strictures and useful temporizing tools for urgent access. Their long-term durability is limited, especially for long, penile, recurrent, ischemic, or complex strictures. After failed dilation or DVIU, repeated endoscopic management usually performs poorly and urethroplasty should be offered. Adjuncts such as mitomycin C, intermittent self-dilation, and drug-coated balloons can improve selected endoscopic outcomes, but they do not change the central rule: endoscopy is best for favorable short strictures, while recurrent or complex disease needs reconstruction.
References
- Wessells H, Morey A, Souter L, Rahimi L, Vanni A. Urethral stricture disease guideline amendment (2023). J Urol. 2023;210(1):64-71. doi:10.1097/JU.0000000000003482.
- Hampson LA, McAninch JW, Breyer BN. Male urethral strictures and their management. Nat Rev Urol. 2014;11(1):43-50. doi:10.1038/nrurol.2013.275.
- Wong SS, Aboumarzouk OM, Narahari R, O'Riordan A, Pickard R. Simple urethral dilatation, endoscopic urethrotomy, and urethroplasty for urethral stricture disease in adult men. Cochrane Database Syst Rev. 2012;12:CD006934. doi:10.1002/14651858.CD006934.pub3.
- Elliott SP, Coutinho K, Robertson KJ, et al. One-year results for the ROBUST III randomized controlled trial evaluating the Optilume drug-coated balloon for anterior urethral strictures. J Urol. 2022;207(4):866-875. doi:10.1097/JU.0000000000002346.
- Goulao B, Carnell S, Shen J, et al. Surgical treatment for recurrent bulbar urethral stricture: a randomised open-label superiority trial of open urethroplasty versus endoscopic urethrotomy (the OPEN trial). Eur Urol. 2020;78(4):572-580. doi:10.1016/j.eururo.2020.06.003.
- Gelman J, Liss MA, Cinman NM. Direct vision balloon dilation for the management of urethral strictures. J Endourol. 2011;25(8):1249-1251. doi:10.1089/end.2011.0034.
- Beeder LA, Cook GS, Nealon SW, et al. Long-term experience with balloon dilation for short bulbar and membranous urethral strictures: establishing a baseline in the active drug treatment era. J Clin Med. 2022;11(11):3095. doi:10.3390/jcm11113095.
- Klein R, Vasan R, Guercio C, Rusilko P. Minimally invasive management of posterior urethral stricture/stenosis with DVIU and mitomycin C injection. Urology. 2024;183:e317-e319. doi:10.1016/j.urology.2023.10.006.
- Kluth LA, Ernst L, Vetterlein MW, et al. Direct vision internal urethrotomy for short anterior urethral strictures and beyond: success rates, predictors of treatment failure, and recurrence management. Urology. 2017;106:210-215. doi:10.1016/j.urology.2017.04.037.
- Pickard R, Goulao B, Carnell S, et al. Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT. Health Technol Assess. 2020;24(61):1-110. doi:10.3310/hta24610.
- Stormont TJ, Suman VJ, Oesterling JE. Newly diagnosed bulbar urethral strictures: etiology and outcome of various treatments. J Urol. 1993;150(5 Pt 2):1725-1728. doi:10.1016/s0022-5347(17)35879-2.
- Jackson MJ, Veeratterapillay R, Harding CK, Dorkin TJ. Intermittent self-dilatation for urethral stricture disease in males. Cochrane Database Syst Rev. 2014;(12):CD010258. doi:10.1002/14651858.CD010258.pub2.
- Scheipner L, Jankovic D, Jasarevic S, et al. Patient reported outcomes of intermittent self-dilatation after direct vision internal urethrotomy. Neurourol Urodyn. 2024;43(3):664-671. doi:10.1002/nau.25390.
- Pang KH, Chapple CR, Chatters R, et al. A systematic review and meta-analysis of adjuncts to minimally invasive treatment of urethral stricture in men. Eur Urol. 2021;80(4):467-479. doi:10.1016/j.eururo.2021.06.022.
- Farrell MR, Lawrenz CW, Levine LA. Internal urethrotomy with intralesional mitomycin C: an effective option for endoscopic management of recurrent bulbar and bulbomembranous urethral strictures. Urology. 2017;110:223-227. doi:10.1016/j.urology.2017.07.017.
- Rozanski AT, Zhang LT, Holst DD, et al. The effect of radiation therapy on the efficacy of internal urethrotomy with intralesional mitomycin C for recurrent vesicourethral anastomotic stenoses and bladder neck contractures: a multi-institutional experience. Urology. 2021;147:294-298. doi:10.1016/j.urology.2020.09.035.
- Sukumar S, Elliott SP, Myers JB, et al. Multi-institutional outcomes of endoscopic management of stricture recurrence after bulbar urethroplasty. J Urol. 2018;200(4):837-842. doi:10.1016/j.juro.2018.04.081.
- Bandini M, Basile G, Lazzeri M, et al. Optimizing decision-making after ventral onlay buccal mucosa graft urethroplasty failure. BJU Int. 2023;131(3):339-347. doi:10.1111/bju.15895.